Year in review

Annual Reporting 2021

We continue to make good progress on our Expand and Invest to Grow strategy and revitalizing our pipeline. Our strategic brands continued to grow across the world. We also saw continued solid revenue growth in International Markets and Europe.

Letter to Shareholders

Our Expand and Invest to Grow strategy launched in 2019 is beginning to show tangible results. We have made good progress on expanding our early- and mid-stage pipeline, based around our expanded operating space. Our newest strategic brand, Vyepti®, continues to grow and gain momentum due to its proven efficacy for patients.

9,287

Revenue from strategic brands (DKKm)

2,010

Profit from operations (EBIT) (DKKm)

3,189

Net debt (DKKm)

16,299

Total revenue (DKKm)

1,318

Net profit (DKKm)

3,823

Research and developement costs (DKKm)

Strategy update

Since launching our Expand and Invest to Grow strategy in 2019, we continue to make strong progress, fueled by our purpose, to restore brain health so every person can be their best.

 

We have taken significant strides to expand our operating space through the acquisitions of Abide and Alder in 2019, which gave us the platforms needed to expand our areas of focus in neuroscience. With the 2020 launch of Vyepti® in the U.S. and the global roll-out which was initiated in 2021, we are beginning to establish a new frontier in migraine prevention and expanding our presence into protein-based therapies. Furthermore, we are continuously expanding our existing portfolio of medicines into new markets.

Strategic imperatives

Sustainability highlights

2021 marks the second year of Lundbeck’s Sustainability Strategy launched in early 2020. We are already seeing strong progress towards many of our 2030 aspirations, not least due to the foundation laid over decades. We are continuously striving to improve and are steadfast in our commitment to building our business sustainably and are confident we will achieve our long-term goals.

937

Patients estimated to have been reached with our donation partnership in low- and middle-income countries.

99.7%

Employees completed the annual e-learning on the Code of Conduct.

 

16%

Reduction in scope 1 & 2 carbon emissions vs. 2019 SBTi target baseline.

65%

We outperformed the target to recover and reuse 60% of the organic compounds used in chemical production. Targets are set annually based on expected production volume and mix.

 

 

42%

The level of women in management is high with a gender split for people managers globally of 42% women and 58% men.

 

 

 

6.5*

*Frequency of lost time accidents per one million working hours. 

 

We have seen an increase in our accident rate this yearcompared to previous years. Even though a smaller share of theaccidents were serious, we are determined to bend this curve.

Downloads

Please find below download links to all the published 2021 reports, incl. Corporate Governance Report, Remuneration Report, Sustainability Report and Annual Report.